These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22294377)

  • 1. Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds.
    Sykes DA; Dowling MR; Charlton SJ
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.14. PubMed ID: 22294377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics.
    Guo D; van Dorp EJ; Mulder-Krieger T; van Veldhoven JP; Brussee J; Ijzerman AP; Heitman LH
    J Biomol Screen; 2013 Mar; 18(3):309-20. PubMed ID: 23093571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach.
    Packeu A; Wennerberg M; Balendran A; Vauquelin G
    Br J Pharmacol; 2010 Nov; 161(6):1311-28. PubMed ID: 20946109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
    Berry J; Price-Jones M; Killian B
    Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds.
    Sykes DA; Jain P; Charlton SJ
    Mol Pharmacol; 2019 Sep; 96(3):378-392. PubMed ID: 31436538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding assays at equilibrium: validation and interpretation.
    Hulme EC; Trevethick MA
    Br J Pharmacol; 2010 Nov; 161(6):1219-37. PubMed ID: 20132208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
    Uhlén S; Schiöth HB; Jahnsen JA
    Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
    Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
    Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.
    Shimizu Y; Ogawa K; Nakayama M
    J Biomol Screen; 2016 Aug; 21(7):729-37. PubMed ID: 27270099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for calculating the dissociation constant of a receptor (or enzyme).unlabeled ligand complex from radioligand displacement measurements.
    Martin RL; Renosto F; Segel IH
    Arch Biochem Biophys; 1991 Jan; 284(1):26-9. PubMed ID: 1989501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor.
    Xia L; de Vries H; IJzerman AP; Heitman LH
    Purinergic Signal; 2016 Mar; 12(1):115-26. PubMed ID: 26647040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects of radioligand binding.
    McKinney M; Raddatz R
    Curr Protoc Pharmacol; 2006 Jul; Chapter 1():Unit1.3. PubMed ID: 22294165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIMUL: an accurate method for the determination of receptor subtype proportions using a personal computer.
    Williams DW; Summers RJ
    Comput Methods Programs Biomed; 1990 Jun; 32(2):137-9. PubMed ID: 2397637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro muscarinic receptor radioligand-binding assays.
    Steinfeld T; Pulido-Rios MT; Armstrong S; Hegde SS
    Curr Protoc Pharmacol; 2010 Mar; Chapter 1():Unit 1.33. PubMed ID: 22294363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.
    Talmont F; Garcia LP; Mazarguil H; Zajac JM; Mollereau C
    Neurochem Int; 2009 Dec; 55(8):815-9. PubMed ID: 19682524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.